Two cases of squamous cell carcinoma treated with topical imiquimod 5%

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 1, 2004, Pages 93-95

  Oster Schmidt, C ^a  

^a NONE   (Germany)

Author keywords

Case reports; Imiquimod; Immune response modulator; Squamous cell carcinoma

Indexed keywords

IMIQUIMOD; IMMUNOMODULATING AGENT;

AGED; ARTICLE; CANCER SURGERY; CASE REPORT; CREAM; DRUG EFFICACY; DRUG INDICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MONOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; VIRUS INFECTION; WART VIRUS;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; SKIN NEOPLASMS;

EID: 0742289604     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00852.x     Document Type: Article

References (12)

1. Braun-Falco O et al. Dermatology, 2nd ed. Springer Verlag, 2000: 1456-1457.
2. Petter G, Haustein U-F. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000; 26(6): 521-530.
3. Persaud AN, Shamuelova E, Sherer D et al. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol 2002; 47(4): 553-556.
4. Stockfleth E, Meyer T, Benninghoff B et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-1502.
5. Mackenzie-Wood A, Kossard S, De Launey J et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44: 462-470.
6. Miller RL, Gerster JF, Owens ML et al. Imiquimod applied topically: a novel immune response modifier and new class of drug. Review article. Int J Immunopharmacol 1999; 21: 1-14.
7. Marks R, Gebauer K, Shumack S et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-813.
8. Geisse JK, Rich P, Pandya A et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47: 390-398.
9. Cowen E, Mercurio MG, Gaspari AA. An open case series of patients with basal cell carcinoma treated with topical imiquimod 5% cream. J Am Acad Dermatol 2002; 47 (4 Suppl.): S240-S248.
10. Orengo I, Rosen T, Guill CK. Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report. J Am Acad Dermatol 2002; 47 (4 Suppl.): S225-S228.
11. Zampogna JC, Flowers FP, Roth WI et al. Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod 5% monotherapy: two case reports. J Am Acad Dermatol 2002; 47 (4 Suppl.): S229-S235.
12. Rösener I, Beermann T, Grußendorf-Conen EI. Therapie eines retroaurikulären Plattenepithelkarzinoms durch Kombination chirurgischer Techniken und topischer Anwendung von Imiquimod. Z Hautkr 2002; 77: 389-391.